![](https://images.squarespace-cdn.com/content/v1/636934fdbb8bde6edeb455cd/5fdbc780-5a63-48ab-9fd3-ccdf6f4b608e/Verpora-Knowledge-bg.jpg)
Knowledge & Resources
Expert insights and knowledge on global Innovative Contracting, VBA,
Market Access and Human Performance Factors
Innovative Contracting & VBA
Articles & Whitepapers
![An Update on Novartis’ Ambitious Leqvio Strategy in the US](https://images.squarespace-cdn.com/content/v1/636934fdbb8bde6edeb455cd/1698856680448-VYCDNAIWS2MP52GLGZN2/Article-Brief-Leqvio.png)
An Update on Novartis’ Ambitious Leqvio Strategy in the US
An update on Novartis’ ambitious Leqvio strategy in the U.S.: On Tuesday, in the investor call to announce their interim (Q3) results, the company gave an update on the product’s roll-out.